Early inflammatory bowel disease study
Part of Digestive system clinical trials.
This trial looks at early signs of inflammatory bowel disease (IBD) in adults who have had stomach or bowel symptoms for at least 3 weeks. It aims to understand how the disease progresses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had stomach or bowel symptoms such as diarrhea, bleeding from the rectum, belly pain, feeling like you need to go to the bathroom often or urgently for at least 3 weeks
- You do not have a confirmed infection in your stomach or bowels
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study follows children with inflammatory bowel disease (IBD) to learn more about the disease and improve care. It may help doctors understand how to treat Crohn's disease, ulcerative colitis, or IBD that doesn't fit either diagnosis.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study looks at healthy family members of people with Crohn's disease or ulcerative colitis to find early signs of these conditions before symptoms appear. It may help doctors predict and prevent inflammatory bowel disease.
This study looks at using precision medicine to treat inflammatory bowel disease (IBD) in people who are newly diagnosed or already being monitored. It aims to find better ways to manage the condition.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.